#Canada #Toronto #Access Program #Xtalks #therapy speed

Enhancing Speed to Therapy in Specialty and Rare Disease Programs

As the pharmaceutical landscape becomes increasingly complex, the need to accelerate therapy delivery for patients with specialty and rare diseases is more paramount than ever. On September 15, 2026, Xtalks will host a free webinar aimed at exploring effective strategies for evaluating access program processes and improving vendor transitions, crucial for reducing delays in therapy.

The event will feature expert speaker Paul Battaglia, Chief Operating Officer of Elusa Health, who will shed light on essential operational queries and performance metrics that pharmaceutical teams should prioritize during evaluations. Often, companies rely on a flood of automation promises, overlooking the real-world implications on patient access to therapies that these transitions can create. Battaglia’s wealth of experience in navigating hub vendor transitions will help attendees gain insights into the underlying operational truths of specialty drug access.

Key Focus Areas of the Webinar

This insightful session will cover several critical topics:

• - Operational Questions: What should inform every hub vendor evaluation? Battaglia will highlight the questions that seek to uncover vendor capabilities beyond the surface level.
• - Performance Metrics: Participants will learn about pivotal performance signals that many brands fail to monitor adequately, potentially jeopardizing patient access.
• - Automation vs Reality: The discussion will tackle the paradoxical relationship between automation in access workflows and its implications on actual patient experiences. It will delve into scenarios where automation fails to alleviate real-world complications, giving rise to execution gaps.
• - Framework for Vendor Assessment: Attendees will walk away with a practical framework for assessing vendor readiness, helping them to support continuity during program transitions significantly.

Importance of Speed in Therapy

In specialty and rare disease areas, where patients often face fragile health conditions and complex prior authorization pathways, every second counts. Delay in access can have dire consequences, amplifying the need for responsive and efficient processes.

The true costs associated with vendor switching during these transitions will also be scrutinized. Participants will gain a nuanced understanding of the repercussions when incomplete data drives high-speed decision-making. The webinar aims to differentiate between vendors that merely market access performance versus those that genuinely deliver on their promises of reliability and speed.

Mark your calendars for Tuesday, September 15, 2026, at 10 AM EDT (4 PM CEST) and equip yourself with strategies that could transform your approach to access programs. Register now and secure your spot in advancing the landscape of specialty disease therapies.

Xtalks stands at the forefront of the life sciences community, delivering essential knowledge and networking opportunities for professionals across pharmaceutical, biotechnology, and healthcare sectors. This upcoming webinar promises to be a pivotal resource for those investing in transformative healthcare solutions.

For more details about registration and the session, visit Xtalks's homepage. Attendees are encouraged to bring their questions and engage in discussions that could shape future strategies in access program evaluations.

Join this event to not only stay informed but to also contribute to a movement seeking to enhance the accessibility and speed of critical therapies.